LET’S TALK INNOVATION. TEAM About us Our team TECHNOLOGY Our platform PARTNERSHIP Partner with us NEWS & EVENTS In the news Press kit CAREERS Work with us Current openings CONTACT US AbCellera Biologics Inc. 2215 Yukon Street Vancouver, BC V5Y 0A1 office: 604.559.9005 LEGAL Privacy policy

close disclaimer Cookies on this website. We use cookies on investors.abcellera.com to provide you with the best possible experience. If you wish to review the cookies we store, please select the Cookie Preferences option on this banner. After your preferences are saved, you can use the cookie icon at the left to modify your selections at any time. ACCEPT COOKIE PREFERENCES NO, THANKS These cookies are necessary for the services and viewing experience of this site, and cannot be opted out of via this tool. If you still wish to remove these, you may do using your browser settings. Read More of stock information NASD: ABCL14.02$ -0.40 ( -2.77% )1,103,626min 20m delay INVESTOR RELATIONS CORPORATE OVERVIEW AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, AI-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. VIEW PRESENTATION LATEST NEWS Loading ... VIEW ALL NEWS INNOVATION. © 2021 AbCellera Biologics Inc. - All rights reserved TEAM About us Our team TECHNOLOGY Our platform PARTNERSHIP Partner with us NEWS & EVENTS In the news Press kit CAREERS Work with us Current openings CONTACT US AbCellera Biologics Inc. 2215 Yukon Street Vancouver, BC V5Y 0A1 office: 604.559.9005 LEGAL Privacy Policy